Immunovant (IMVT) Insider Trading & Ownership $14.67 +0.22 (+1.50%) As of 11:20 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunovant (NASDAQ:IMVT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$336.90 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$5.35 M Get IMVT Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMVT Insider Buying and Selling by Quarter Immunovant Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/16/2025Eva Renee BarnettCFOSell2,993$14.89$44,565.77 4/16/2025Peter SalzmannCEOSell8,321$14.89$123,899.69 4/9/2025Peter SalzmannCEOSell28,094$12.99$364,941.06 3/7/2025Andrew J FromkinDirectorSell8,000$19.60$156,800.00 1/22/2025Jay S StoutCTOSell2,195$23.59$51,780.05 1/22/2025Michael GeffnerInsiderSell2,657$23.59$62,678.63 1/15/2025Eva Renee BarnettCFOSell2,298$23.83$54,761.34 1/15/2025Peter SalzmannCEOSell8,767$23.83$208,917.61 1/15/2025William L MaciasInsiderSell2,383$23.83$56,786.89 1/13/2025Sciences Ltd. RoivantDirectorBuy16,845,010$20.00$336,900,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/8/2025Eva Renee BarnettCFOSell4,105$24.10$98,930.50 1/8/2025Peter SalzmannCEOSell5,105$24.10$123,030.50 11/20/2024Eva Renee BarnettCFOSell4,174$25.45$106,228.30 11/20/2024Eva Renee BarnettCFOSell4,174$25.45$106,228.30 11/20/2024Mark S LevineInsiderSell3,650$25.45$92,892.50 11/20/2024Peter SalzmannCEOSell16,692$25.45$424,811.40 11/20/2024Peter SalzmannCEOSell16,692$25.45$424,811.40 10/23/2024Jay S StoutCTOSell2,740$29.53$80,912.20 10/23/2024Mark S LevineInsiderSell4,361$29.53$128,780.33 10/16/2024Eva Renee BarnettCFOSell3,271$28.79$94,172.09 10/16/2024Peter SalzmannCEOSell9,095$28.79$261,845.05 10/16/2024William L MaciasInsiderSell3,188$28.79$91,782.52 10/9/2024Eva Renee BarnettCFOSell5,162$29.56$152,588.72 10/9/2024Peter SalzmannCEOSell4,460$29.56$131,837.60 7/24/2024Jay S StoutCTOSell2,813$27.76$78,088.88 7/24/2024Michael GeffnerInsiderSell3,456$27.76$95,938.56 7/17/2024Eva Renee BarnettCFOSell3,123$29.69$92,721.87 7/17/2024Mark S LevineInsiderSell2,505$29.69$74,373.45 7/17/2024Peter SalzmannCEOSell8,685$29.69$257,857.65 7/9/2024Eva Renee BarnettCFOSell4,747$28.06$133,200.82 7/9/2024Julia G ButchkoInsiderSell1,527$28.06$42,847.62 7/9/2024Peter SalzmannCEOSell4,619$28.06$129,609.14 5/22/2024Eva Renee BarnettCFOSell4,042$29.65$119,845.30 5/22/2024Julia G ButchkoInsiderSell3,247$29.65$96,273.55 5/22/2024Peter SalzmannCEOSell16,163$29.65$479,232.95 4/24/2024Jay S StoutCTOSell7,239$28.90$209,207.10 4/24/2024Michael GeffnerInsiderSell3,261$28.90$94,242.90 (Data available from 1/1/2013 forward) IMVT Insider Trading Activity - Frequently Asked Questions Who is on Immunovant's Insider Roster? The list of insiders at Immunovant includes Andrew J Fromkin, Eva Renee Barnett, Frank Torti, Jay S Stout, Julia G Butchko, Mark S Levine, Michael Geffner, Peter Salzmann, Sciences Ltd. Roivant, and William L Macias. Learn more on insiders at IMVT. What percentage of Immunovant stock is owned by insiders? 5.90% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings. Which Immunovant insiders have been buying company stock? The following insider purchased IMVT shares in the last 24 months: Sciences Ltd. Roivant ($394,900,208.00). How much insider buying is happening at Immunovant? Insiders have purchased a total of 18,371,326 IMVT shares in the last 24 months for a total of $394,900,208.00 bought. Which Immunovant insiders have been selling company stock? The following insiders have sold IMVT shares in the last 24 months: Andrew J Fromkin ($156,800.00), Eva Renee Barnett ($2,388,454.80), Jay S Stout ($419,988.23), Julia G Butchko ($714,853.04), Mark S Levine ($964,453.35), Michael Geffner ($252,860.09), Peter Salzmann ($10,663,584.23), and William L Macias ($204,386.18). How much insider selling is happening at Immunovant? Insiders have sold a total of 640,979 Immunovant shares in the last 24 months for a total of $15,765,379.92 sold. Immunovant Key ExecutivesDr. Frank M. Torti M.B.A. (Age 45)M.D., Executive Chairperson of the Board Compensation: $92.5kDr. Peter Salzmann M.B.A. (Age 56)M.D., CEO & Director Compensation: $1.02MMs. Eva Renee Barnett M.B.A. (Age 43)Chief Financial Officer Compensation: $871.07k5 recent tradesDr. William L. Macias M.D. (Age 65)Ph.D., Chief Medical Officer Compensation: $719.88kDr. Jay S. Stout Ph.D. (Age 60)Chief Technology Officer Dr. Chau Cheng M.B.A.Ph.D., Vice President of Investor RelationsMr. Mark S. Levine (Age 51)Chief Legal Officer & Corporate Secretary 1 recent tradesMs. Lauren Schrier M.B.A.Vice President of MarketingMs. Christine BlodgettVice President of Human ResourcesDr. Julia G. Butchko Ph.D. (Age 53)Chief Development Officer Compensation: $531k More Insider Trading Tools from MarketBeat Related Companies MRNA Insider Trading VTRS Insider Trading ROIV Insider Trading LNTH Insider Trading RVMD Insider Trading BBIO Insider Trading TGTX Insider Trading BPMC Insider Trading SRPT Insider Trading AXSM Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:IMVT) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.